Out of 234 patients included into final analysis , the total of 34.2 % ( n = 80 ) patients displayed HPR , of which 14.1 % ( n = 33 ) were randomized into 150 mg of ASA group and 20.1 % ( n = 47 ) into 75 mg of clopidogrel group .